Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) ...

FDA Recall #D-0178-2021 — Class II — December 17, 2020

Recall #D-0178-2021 Date: December 17, 2020 Classification: Class II Status: Terminated

Product Description

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88

Reason for Recall

Failed Impurity/Degradation Specifications

Recalling Firm

Ascend Laboratories LLC — Parsippany, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

29,317 bottles

Distribution

Nationwide

Code Information

20141674, 20141675, 20141676, 20141677, 20141678,

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated